Company Omnimmune Holdings, Inc. Other OTC
Equities
OMMH
US68216A1043
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2008 | Weight | 2009 | Weight | Delta |
---|---|---|---|---|---|
Cancer Therapeutic
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2008 | Weight | 2009 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,355,921 | 3,941,372 ( 42.13 %) | 0 | 42.13 % |
Company contact information
Omnimmune Holdings, Inc.
4600 Post Oak Place Suite 352
77027, Houston
+
Sector
1st Jan change | Capi. | |
---|---|---|
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+45.83% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |